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ABSTRACT
Astrocytes are key players in brain function; they are
intimately involved in neuronal signalling processes and
their metabolism is tightly coupled to that of neurons. In
the present review, we will be concerned with a discussion
of aspects of astrocyte metabolism, including energy-
generating pathways and amino acid homoeostasis. A
discussion of the impact that uptake of neurotransmitter
glutamate may have on these pathways is included along
with a section on metabolic compartmentation.
Key words: amino acid, astrocyte, compartmentation,
energy, metabolism.
ASTROCYTE ENERGY METABOLISM
Glucose entry, phosphorylation and generation
of glycogen in astrocytes
Astrocytes are ideally positioned to sense synaptic activity in
the brain (Kacem et al., 1998), they control blood flow (Gordon
et al., 2008; Allen and Barres, 2009), interact with neurons and
endothelial cells (Vesce et al., 1999) and likely act as signalling
integrators at different temporal and spatial domains (Parpura
and Zorec, 2010; Parpura et al., 2010). Astrocytic endfeet lie
between all brain capillaries and neuronal terminals
(Tsacopoulos and Magistretti, 1996; Mathiisen et al., 2010)
and during neuronal activity astrocytes may exhibit an
increased glucose uptake and possibly have a key role in
coupling synaptic activity to glucose utilization (Magistretti,
2006) and provision of glucose for neuronal metabolism
(DiNuzzo et al., 2010, 2011). Sodium-coupled uptake of
glutamate by astrocytes and the ensuing activation of the
Na
+/K
+-ATPase may trigger glucose uptake and glycolytic
processing (Fox et al., 1988, Magistretti, 2006), the latter
process providing energy in the form of ATP to fuel glutamate
uptake (Schousboe et al., 2011).
The [glc]i (intracellular glucose concentration) is dependent
on the [glc]e (external glucose concentration), but is limited to
a maximal value of ,0.4 mM (Bittner et al., 2010; Prebil et al.,
2011a). This upper limit is likely due to the plasma membrane
permeability for glucose, which is in balance with the cytosolic
glucose utilization. The rate of glucose flux through GLUT1
(glucose transporter 1), the major GLUT in astrocytes (Loaiza
et al., 2003), is thus in balance with the rate of utilization by
hexokinase activity. Interestingly, the level of [glc]i in
astrocytes (0.4 mM) is much lower than that measured
in 3T3-L1 fibroblasts (10.2 mM) and preadipocytes (2.6 mM),
but comparable with adipocytes (0.6 mM) (Kovacic et al.,
2011), determined at similar extracellular glucose levels.
In astrocytes, the cytosolic glucose concentration declines
to a new lower steady-state value in approximately 20 s,
when extracellular glucose changes from 0.5 to 0.0 mM. At
higher initial extracellular glucose level (i.e. 5 mM; higher
load for the metabolism), the decline in cytosolic glucose
concentration is slower (60 s), which is likely due to the rate-
limited cytosolic consumption of glucose (Prebil et al., 2011a).
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asnneuro.org / Volume 4 (3) / art:e00086 187GLUT1 (45-kDa isoform) is located in the astrocytic endfeet
around blood vessels (Morgello et al., 1995) and in astrocytic
cell bodies and processes (Leino et al., 1997). The GLUT2 was
also found in astrocytes (Leloup et al., 1994; Leino et al.,
1997; Arluison et al., 2004). On the other hand, the 55-kDa
isoform of GLUT1 is located in endothelial cells which form
the blood–brain barrier. Glucose enters neurons trans-
cellularly through astrocytes via the 45-kDa isoform of
GLUT1 or directly via GLUT3, a neuronal GLUT (Maher et al.,
1994). It may be noted that GLUT1 is stimulated by glutamate
in vitro and by neuronal activity in vivo (Loaiza et al., 2003;
Porras et al., 2008; Chuquet et al., 2010).
After glucose entry, glucose is phosphorylated by type I
hexokinase (Needels and Wilson, 1983; Griffin et al., 1992). In
astrocytes, most of the type I hexokinase is associated with
mitochondria (Lynch et al., 1991), and the activity of
hexokinase bound to mitochondria is greater than the
cytosolic hexokinase (Nagamatsu et al., 1996). However,
inhibition of gap junctions promotes the translocation of
type I hexokinase from mitochondria towards microtubules,
and induces a significant expression of type II hexokinase and
GLUT3, which are normally not present in astrocytes; all these
changes aid to sustain a higher rate of cell proliferation
(Sa ´nchez-Alvarez et al., 2004). It was shown that levels of
glucose-1,6-bisphosphate higher than 0.2 mM inhibit astro-
glial hexokinase in a concentration-dependent manner; at
1.2 mM, the hexokinase activity is almost completely
inhibited (Lai et al., 1999). Endothelin-1, a vasoconstricting
agent (Nie and Olsson, 1996), stimulates the translocation
and up-regulation of both GLUT1 transporter and type 1
hexokinase in astrocytes (Sa ´nchez-Alvarez et al., 2004). Type
II hexokinase is induced by deprivation of glucose (Niitsu
et al., 1999). It was recently shown that ischaemic stress
increases the expression of GLUT3, which is responsible for
the enhanced storage of intracellular glucose during
reperfusion (Iwabuchi and Kawahara, 2011).
After glucose phosphorylation, glucose-6-phosphate is the
intermediate from which either glycolysis, the pentose–
phosphate pathway or the generation of glycogen may start
(Figure 1). The amount of glucose metabolized in the
pentose–phosphate pathway is less than one-tenth compared
with glycolysis in cultured astrocytes (Leo et al., 1993; Ben-
Yoseph et al., 1994), where lactate is a major metabolic
product (Wiesinger et al., 1997). Several toxic agents, such as
chlorinated acetates, fluoxetine, ethanol and copper, were
shown to disturb glucose uptake or metabolism in astrocytes
(Abdul Muneer et al., 2011; Allaman et al., 2011; Scheiber and
Dringen, 2011; Schmidt et al., 2011).
It was reported that in rat brain the extracellular
concentration of glucose, measured by a microdialysis
technique, is as low as 0.47 mM (Fellows et al., 1992).
Moreover, in ischaemic conditions, the extracellular glucose
concentration, measured with micro-electrodes, is less than
0.05 mM, and in hypoglycaemia less than 0.19 mM (Silver
and Erecin ´ska, 1994), which may be the milieu where glucose
may leak out of the astrocyte, since the resting cytosolic
glucose concentration was measured to be 0.4 mM, especially
if noradrenalin is present (Prebil et al., 2011a).
Emerging evidence suggests that metabolic substrates
other than glucose (e.g. glycogen, lactate and glutamate)
provide significant amounts of energy in the brain (Brown
et al., 2001; Dienel and Cruz, 2006). In the brain, glycogen
(Cataldo and Broadwell, 1986; Wender et al., 2000) as well as
GP (glycogen phosphorylase) predominantly reside in astro-
cytes (Ibrahim, 1975). The term glycogen shunt (Figure 1)
represents the fraction of metabolized glucose that passes
through glycogen molecules, prior to entering the glycolytic
pathway, and may be as large as 40% of overall glucose
metabolism (Walls et al., 2009). The glycogen reservoir can
provide fuel for energy production during hypoglycaemia
(Swanson and Choi, 1993; Brown and Ransom, 2007), as well
as during normal brain metabolism (Swanson, 1992; Fillenz
et al., 1999; Walls et al., 2009). Glycogen content appears to
be dependent on insulin signalling in astrocytes (Heni et al.,
2011).
Glycolysis and glycogenolysis appear to provide most of the
energy required during an abrupt energy demand (Hertz et al.,
2007). Glycogen might serve as a source of lactate which may
be transferred to neurons (Wender et al., 2000; DiNuzzo et al.,
2011), or converted to pyruvate, which enters the TCA
(tricarboxylic acid) cycle (Sickmann et al., 2005). Lactate and
ketone bodieshavebeen shownto fuela substantialportionof
brain-energy metabolism in prolonged starvation, diabetes
and under hypoglycaemia (reviewed by Pellerin and
Magistretti, 2004). In addition, lactate may act as a signalling
molecule(reviewedby Barrosand Deitmer, 2010). On theother
hand, astrocytic networks can also effectively remove lactate
from activated glycolytic domains, and the lactate can be
dispersed throughout the syncytium to the endfeet for release
to blood (Gandhi et al., 2009). Finally, channelling of blood-
borne glucose to the extracellular space for use in neurons has
been suggested by DiNuzzo et al. (2010, 2011) based on the
idea that breakdown of glycogen inhibits phosphorylation by
hexokinase.
Effects of glutamate entry on energy metabolism
A FRET (fluorescence resonance energy transfer)-based
approach employing nanosensors (Fehr et al., 2003) may be
reliably used to monitor dynamic activity-induced changes in
cytosolic glucose levels in astrocytes (Bittner et al., 2010,
2011; Prebil et al., 2011a, 2011b). In the first generation of
such nanosensors, such as FLIPglu-600m, a decrease in the
FRET signal was observed upon glucose binding (Takanaga et
al., 2008). The second generation of nanosensors, such as
FLII12PGLU-700mD6, have an improved signal-to-noise ratio
and a higher dynamic measuring range in vivo, from 0.05 to
9.6 mM (Takanaga et al., 2008). Phosphorylated sugars have
no effect on the FRET ratio (Fehr et al., 2003). To dynamically
monitor the cytosolic glucose concentration ([glc]i), the CFP
(cyan fluorescence protein) fluorescence is excited and the
fluorescence of CFP and YFP (yellow fluorescence protein) is
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a defined region of the imaged cell. Cells superfused with
extracellular medium, containing a high glucose concentra-
tion, display high intensity of CFP fluorescence and low
intensity of YFP fluorescence. Thus, the high YFP/CFP ratio
(DR) indicates an elevated cytosolic glucose concentration.
The exchange of glucose-rich external solution with the one
devoid of glucose results in the FRET ratio decline, indicating
glucose depletion from the cell (Takanaga et al., 2008).
The sensor may be calibrated in situ by measuring the
difference between the FRET ratio during superfusion with
the increasing extracellular glucose concentration and
intermittent superfusion with a solution devoid of glucose
(DR). To calibrate the sensor, the plasma membrane should be
permeabilized (e.g. by using b-escin) to allow fast and
unhindered access of glucose to the sensor in the cell interior.
The saturation level of the sensor is first calculated (S5DR/
DRmax), and then by using the binding constant Kd of the
sensor the intracellular concentration of glucose is estimated
([glc]i5{Kd6S}/{12S}; Prebil et al., 2011a). It is important
to note that since the sensor measures the level of
unphosphorylated glucose, it is assumed that a decrease in
[glc]i reflects increased utilization of glucose, i.e. increased
uptake and glycolytic breakdown of extracellular glucose.
The effect of glutamate as a neurotransmitter in the synapse
is strongly dependent on astrocytic metabolism (Hertz, 2006).
Since glutamate does not readily cross the blood–brain barrier,
glucose servesasa precursor for glutamate synthesis(Hertzand
Dienel, 2002). Neurons lack the enzyme pyruvate carboxylase
(Yu etal., 1983) and therefore dependonastrocytesfor denovo
synthesis of glutamate (Danbolt, 2001; Hertz and Zielke, 2004).
Rapid glutamate uptake by glial transporters located near
release sites (Chaudhry et al., 1995; Bergles et al., 1997; Clark
and Barbour, 1997; Dzubay and Jahr, 1999) removes the
transmitter and thus terminates the excitatory postsynaptic
potential. In physiological conditions, glutamate uptake into
astrocytes is driven by the electrochemical gradient of sodium
(O’Kane et al., 1999) and mediated mainly through two glial
glutamate transporters: GLAST (EAAT1) and GLT1 (EAAT2)
(Rothstein et al., 1994; Danbolt, 2001).
Figure 1 Glucose and glycogen metabolism in astrocytes
Simplified schematic representation of glucose metabolism via glycolysis or via the ‘glycogen shunt’ illustrating how glucose units
may be metabolized via incorporation into and subsequent hydrolysis from the branched glycogen molecule preceding metabolism to
pyruvate and lactate, i.e. glycogenolysis. Glucose-6-P, glucose-6-phosphate; ETC, electron transport chain.
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189Trafficking of glutamate transporters to the plasma
membrane has been studied (Robinson, 2002; Fournier et al.,
2004; Stenovec et al., 2008) and it is likely that glutamate
transporters get incorporated into the plasma membrane by
exocytosis (Cheng et al., 2002; Stenovec et al., 2008).
Consistent with the presence of a regulated exocytotic
pathway in astrocytes (Kreft et al., 2004; Pangrsic et al., 2006,
2007; Parpura and Zorec, 2010), a calcium-dependent
increase in cumulative exocytosis increases the glutamate
transporter density (Stenovec et al., 2008), which is important
for maintaining a low extracellular glutamate concentration,
essential for the prevention of chronic glutamate neurotoxi-
city (Rothstein et al., 1996).
After glutamate uptake into astrocytes, it is either
converted to glutamine (Figure 2) by the astrocyte-specific
GS (glutamine synthetase; Derouiche, 2004) or at high
glutamate concentration is oxidatively degraded after
conversion to a-KG (a-ketoglutarate; Yu et al., 1982;
McKenna et al., 1996, 2000). The latter pathway (Figure 3)
clearly shows that besides being an excitatory transmitter,
glutamate is an important metabolic fuel, which is oxidatively
metabolized in astrocytes (Miller et al., 1975; Hertz et al.,
1988; Swanson et al., 1990; Zielke et al., 1998; Dienel and
Cruz, 2006; Hawkins, 2009). This aspect is discussed in further
detail in a subsequent section.
Astrocytes respond to glutamate by enhancing both
glucose utilization and lactate production and release
(Pellerin and Magistretti, 1994, 2003; Fray et al., 1996),
which has been suggested to lead to the increase in
extracellular lactate that follows cortical activation (Hu and
Wilson, 1997); however, the exact sources and sinks of
extracellular lactate during activation are still elusive, as
discussed recently by Kasischke (2011), and neurons might
indeed contribute to extracellular lactate (Caesar et al., 2008;
Bak et al., 2009; Contreras and Satrustegui, 2009) as well as
consume at least half of the available extracellular glucose
(Zielke et al., 2007). Glutamate may induce glycolysis in
astrocytes (Pellerin et al., 2007) which is mediated by the ac-
tivation of a Na
+-dependent uptake system rather than the
activation of extracellular glutamate receptors (Pellerin and
Magistretti, 1994); however, others have not been able to
show this coupling between glutamate uptake and stimu-
lation of glycolysis, probably indicating astrocytic diversity
(Hertz et al., 1998, 2007). Using FRET nanosensors for glucose,
it was recently confirmed that glutamate stimulates gly-
colysis in cultured astrocytes, but only after a lag of several
Figure 2 Schematic representations of the proposed amino acid (AA) shuttles at the glutamatergic synapse involved in the return of
ammonia generated in neurons when the glutamate-glutamine cycle is running
In the lactate–alanine shuttle the amino acid (AA) is alanine and the ammonia produced in neurons is fixed into a-KG by the GDH
reaction to form glutamate, then transaminated by alanine aminotransferase into the KA (keto-acid) pyruvate to form alanine which
is exported to astrocytes. In the astrocytes this process is then reversed, and pyruvate is transported in the other direction (it is likely
that pyruvate may be converted to lactate for the transfer process to occur). In the branched-chain AA shuttle the AA is a branched-
chain AA such as leucine. Here, the ammonia fixed in the GDH reaction in the neurons is transaminated into the KA (keto-acid) a-
ketoisocaproate to form leucine, which is exported to astrocytes. In the astrocytes, the process is reversed, i.e. a-ketoisocaproate is
transported in the other direction. Abbreviations: Glc, glucose; Gln, glutamine; Glu, glutamate.
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application of glutamate results in a switch of the astrocytic
metabolism from glycolytic to oxidative, which is manifested
as a stimulation of mitochondrial activity, decreased glucose
uptake and decreased glycolytic lactate production (Dienel,
2004; Liao and Chen, 2003). This may be related to the fact
that glutamate is an energy substrate in astrocytes (Hertz
et al., 2007). It was recently shown that glutamate added to
the extracellular solution containing 3 mM of glucose results
in a significant decrease in cytosolic glucose concentration in
astrocytes (Prebil et al., 2011a). The high glutamate
concentration may interfere with the intermediates of the
TCA cycle (Yu et al., 1982). This suggests that elevated
glutamate may be used by astrocytes as an energy source and
that glucose may be directed towards glycogen synthesis,
hence a decrease in cytosolic glucose concentration. The time-
course of the glucose concentration decrease has a
time-constant of approximately 50 s with a delay to onset of
the change of 24 s after stimulation, comparable with the
delay of glutamate-stimulated hexose uptake (Loaiza et al.,
2003). The glutamate together with K
+ triggers an increase in
the rate of glycolysis in astrocytes (Bittner et al., 2010). On the
other hand, when glutamate is added to a glucose-free
extracellular medium, a slow increase in the cytosolic glucose
concentration was detected (Prebil et al., 2011a). In this case
the glutamate is likely to be used as an energy source (see
Hertz et al., 2007) and it enabled glucose to be spared from
immediate use. This mechanism was confirmed by the inhi-
bition of glycogen mobilization using a GPa inhibitor DAB
(diaminobenzidine), where such an increase in intracellular
glucose after glutamate addition was attenuated (Prebil et al.,
2011a). This confirms that glutamate may be used as an
alternative source of energy (Swanson et al., 1990) and that
the glycogen-derived glucose may be preserved in hypogly-
caemic conditions. The increase in intracellular glucose in
glucose-free extracellular medium is in agreement with the
view that astrocytes may provide an endogenous source of
brain glucose, since they express glucose-6-phosphatase-b
(Forsyth et al., 1993; Ghosh et al., 2005); however, the role of
astrocytes as glucose-releasing cells by this mechanism is
controversial and has to be further investigated (Dringen and
Hamprecht, 1993; Forsyth, 1996).
Figure 3 The extent to which glutamate (GLU) is oxidized in astrocytes seems to increase particularly during higher GLU concentrations
A net synthesis of TCA cycle intermediates occurs when the initial reaction is catalysed by GDH which paves the way for the complete
oxidation of the carbon skeleton of GLU. This requires pyruvate recycling via the concerted action of malic enzyme (ME) and pyruvate
dehydrogenase (PDH) converting malate into acetyl-CoA producing NAD(P)H. Acetyl-CoA is oxidized completely in one turn of the
TCA cycle. A partial oxidation of GLU is acquired when pyruvate (PYR) is reduced to lactate (LAC) instead of being oxidized to acetyl-
CoA. The redox state of the cell is likely important in the regulation of the destiny of the GLU molecule. Alternative to the activity of
GDH, AAT facilitates the formation of a-KG from GLU at the expense of OAA (oxaloacetate); thus no net synthesis of TCA cycle
intermediates is obtained. In contrast to the complete oxidation initiated by the activity of GDH, AAT enables the truncated TCA cycle
which refers to the net synthesis of aspartate from GLU, a pathway shown to accelerate during hypoglycaemic conditions. PC,
pyruvate carboxylase; CIT, citrate.
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191Modulation of glucose metabolism in astrocytes
by noradrenaline, adrenaline and ATP
Receptors for multiple neurotransmitters co-exist on astro-
cytes and can regulate energy metabolism (Magistretti, 1988).
In astrocytes, noradrenaline activates both a-a n db-
adrenergic receptors (Northam et al., 1989; Hertz et al.,
2010), which induces glycogen breakdown (Subbarao and
Hertz, 1990a, 1991; Pellerin and Magistretti, 1994; Fray et al.,
1996; Gibbs et al., 2008; Walls et al., 2009; Obel et al., 2012). In
addition to rapid glycogen breakdown, noradrenaline stimu-
lates long-term glycogen re-synthesis (Pellerin et al., 1997).
The increase in glycogen turnover was found to be dependent
on the activation of a2 adrenergic receptors involving the
Gi/o-PI3K (phosphoinositide 3-kinase) pathway in chick
astrocytes (Hutchinson et al., 2011). Although b1-adrenergic
receptors are the predominant b-adrenergic receptors in
mouse astrocytes, the activation of b2- and b3-adrenergic
receptors was found to increase glucose uptake in mouse
astrocytes(Catuset al.,2011).Noradrenaline-inducedpyruvate
decarboxylation was found to result from an increase in intra-
mitochondrial concentration of Ca
2+ in astrocytes (Chen and
Hertz, 1999). This significantly stimulates the TCA cycle in
astrocytes(Subbaraoand Hertz,1990b,1991).Theinhibitionof
b2-adrenergic stimulation of glycogen synthesis is associated
with cognitive impairment (Hertz and Gibbs, 2009).
An application of adrenaline or noradrenaline results in
increased cytosolic glucose concentration from 0.3 to 0.5 mM,
with the initial rates of [glc]i rising at 1.6 mM/s (Prebil et al.,
2011a). This is similar to the total glycolytic rate (1.8 mM/s)
measured in astrocytes bathed in the GLUT inhibitor
cytochalasin B (Bittner et al., 2010). The b-adrenergic
stimulation of astrocytes modulates cytosolic glucose via
changes in cytosolic cAMP levels (Pellerin et al., 1997). In cells
stimulated with noradrenaline and preincubated with DAB,
a GPa inhibitor, cells displayed only one-third of the [glc]i
increase compared with noradrenaline-stimulated cells
without DAB preincubation (Prebil et al., 2011a). a- and b-
adrenergic receptors induce glycogen breakdown in astrocytes
(Subbarao and Hertz, 1990a, 1991; Pellerin and Magistretti,
1994; Fray et al., 1996; Gibbs et al., 2008) and the increased
availability of cytosolic glucose after adrenaline or noradrena-
line stimulation suggests that the stimulated glycogen
breakdown exceeds the cytosolic glucose utilization in
astrocytes (Prebil et al., 2011a). On the other hand, noradrena-
line-stimulated glucose uptake was also demonstrated (Yu
et al., 1993).
Using the FRET-based glucose nanosensor protein FLIPglu-
600 m in 3T3-L1 fibroblasts and adipocytes revealed that the
changes in cytosolic glucose concentration were only
detected in 56% of 3T3-L1 fibroblasts and in 14% of 3T3-
L1 adipocytes, where insulin increased cytosolic glucose
concentration by a factor of 4. On the other hand, adrenaline
increased cytosolic glucose concentration in fibroblasts but
not in adipocytes (Kovacic et al., 2011). Similarly, adrenaline
inhibits glycogen synthase and activates GP in muscle (Villa-
Moruzzi et al., 1979). In astrocytes, glycogen is continuously
synthesized and degraded (Shulman et al., 2001), and lactate
originating from glycogen is compartmentalized from that
derived from glucose (Sickmann et al., 2005).
ATP is a major factor mediating intercellular communication
and triggers a variety of different biological effects (Brake and
Julius, 1996) and is considered to be the dominant extracel-
lular messenger for astrocyte-to-astrocyte communication
(Cotrina et al., 1998; Guthrie et al., 1999; Wang et al., 2000;
Pangrsic et al., 2007; Parpura and Zorec, 2010). It is released
from astrocytes upon mechanical stimulation (Guthrie et al.,
1999) or glutamatergic receptor activation (Queiroz et al., 1997;
Pangrsic et al., 2007). Astrocytes respond to ATP with a pro-
pagating wave of intracellular calcium increases (Guthrie et al.,
1999), a process that is thought to serve as a long-range
signalling system in the CNS (central nervous system; Cornell-
Bell et al., 1990; Koizumi et al., 2005). ATP stimulation promotes
exocytosis in astrocytes (Pangrsic et al., 2006) and ATP released
from astrocytes as a result of neuronal activity modulates
synaptic transmission (Zhang et al., 2003). Furthermore,
astrocytes are capable of ATP-induced ATP release (Anderson
et al., 2004). It should be noted that there is some controversy
regardingreleaseofATPduringhypoxicconditions(Martı ´n et al.,
2007; Fujita et al., 2012).
ATP is an agonist for P2Y and P2X receptors (Ralevic and
Burnstock, 1998). Primary rat cortical astrocytes express
ligand-gated P2X ion channels (i.e. P2X1–5 and P2X7) and G-
protein-coupled P2Y receptors (i.e. P2Y1, P2Y2, P2Y4, P2Y6 and
P2Y12) (Fumagalli et al., 2003). Up-regulation of receptors in
astrocytes after injury has been found (Franke et al., 2001,
2004). The P2X7 subtype acts also as a permeabilization pore
that can induce cell death under prolonged activation by ATP
(Innocenti et al., 2004). Astrocyte-released ATP mediates a
paracrine activation of microglial P2X7 receptors that triggers
a perturbation of calcium homoeostasis and finally leads to
microglial cell death (Verderio and Matteoli, 2001).
Stimulation of isolated astrocytes with ATP decreases
cytosolic glucose concentration with a time constant of ap-
proximately 150 s (Prebil et al., 2011b). The mechanism of
ATP-dependent glucose concentration decrease is not yet
fully understood, and may potentially affect glucose
transport or metabolism. In astrocytes, purinergic receptors,
particularly the P2X7 subtype, are coupled to the PI3K/Akt
[also known as PKB (protein kinase B)] pathway (Jacques-
Silva et al., 2004). On the other hand, in renal mesangial cells
ATP was reported to activate Akt via the P2Y receptor
(Huwiler et al., 2002). In astrocytes, ATP stimulates Akt
phosphorylation, where calcium, PI3K and a Src family kinase
are involved (Jacques-Silva et al., 2004), which may result in
several cellular downstream effects related to the Akt
pathway, such as glycogen synthesis (Brazil and Hemmings,
2001). Activated (phosphorylated) Akt phosphorylates and
inactivates GSK3 (GS kinase 3), which is a major protein
kinase involved in the regulation of glucose metabolism in
muscle (Medina and Castro, 2008). Inactivated GSK3 results
in less phosphorylated and thus more active glycogen
synthase (Cross et al., 1995; Lawrence and Roach, 1997;
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cytosolic glucose levels as observed in ATP-stimulated
astrocytes (Prebil et al., 2011b). On the other hand,
stimulation of P2X7 receptors is associated with the
activation of PKC (protein kinase C) and phospholipase D in
astrocytes (Sun et al., 1999), which may represent an
alternative pathway of glycogen synthase activation. ATP
stimulation of P2 receptors of rat cortical astrocytes was
shown to result in inhibition of GSK3 activity by a PKC-
dependent pathway that is independent of Akt (Neary and
Kang, 2006).
AMINO ACID METABOLISM
Astrocytes are obviously involved in metabolism of all amino
acids but this review will be focused on the role of astrocytes
in the metabolic homoeostasis of the two major neuroactive
amino acids, glutamate and GABA (c-aminobutyric acid)
mediating the vast majority of excitatory and inhibitory
neurotransmitter signalling respectively. The key enzymes
involved in metabolic reactions pertinent to the turnover of
the neurotransmitters glutamate and GABA as well as their
prevailing cellular localization has recently been reviewed by
Waagepetersen et al. (2009). It should be noted that GS is
exclusively expressed in astrocytes (Norenberg and Martinez-
Hernandez, 1979) and glutamate decarboxylase is only
present in GABAergic neurons and not in astrocytes (Hertz
et al., 1992). In addition, it is of functional importance that
the activity of PAG (phosphate-activated glutaminase) is
higher in neurons than in astrocytes (Schousboe et al., 1979;
Drejer et al., 1985; Larsson et al., 1985; Lovatt et al. 2007).
This difference in the expression level of GS and PAG in
astrocytes forms the basis for the glutamate-glutamine cycle
which was originally proposed on the basis of studies of
glutamate and glutamine metabolism in brain tissue
preparations which indicated different cellular compartments
of these amino acids with different turnover rates (Berl
et al., 1961, 1962; Van den Berg and Garfinkel, 1971). The
glutamate–glutamine cycle is in short the clearance of glu-
tamate from the synaptic cleft by uptake into astrocytes and
the subsequent amidation of glutamate into glutamine which
is transferred into neurons for re-synthesis of glutamate
(Figure 2). Hence the cycle leads to a net transfer of nitrogen
from the astrocytic to the neuronal compartment. In order to
maintain nitrogen homoeostasis in the ‘tripartite’ micro-
environment, i.e. the pre- and post-synaptic neuron and the
surrounding astrocyte, this nitrogen must be transferred back
to the astrocyte (Figure 2). This may be accomplished by
transfer of an amino acid, e.g. alanine, which is thought to be
transaminated forming glutamate from which the amino
group may be liberated by the action of GDH (glutamate
dehydrogenase; Waagepetersen et al. 2000; Schousboe et al.,
2003; Bak et al., 2006). The amino group may subsequently
take part in the GS reaction. For the shuttle to operate
stoichiometrically, the GDH reaction has to operate in both
directions, i.e. reductive amination in neurons and oxidative
deamination in astrocytes. The high content of ammonia in
the glutamatergic neurons may overcome the problem that
deamination seems to be favoured (Plaitakis and Zaganas,
2001). Additionally, the branched chain amino acids have
been proposed to provide the amino nitrogen for de novo
synthesis of glutamate via pyruvate carboxylation in astro-
cytes followed by amidation by GS and transfer of glutamine
to the neurons (Lieth et al., 2001). In order for the glutamate–
glutamine cycle to operate stoichiometrically, all glutamate
taken up by astrocytes via high affinity glutamate transpor-
ters (Danbolt, 2001) must be converted to glutamine in the
GS-catalysed reaction (Cotman et al., 1981). However,
numerous metabolic studies have demonstrated considerable
oxidative metabolism of glutamate via the TCA cycle (Yu et al.,
1982; McKenna et al, 1996; Sonnewald et al., 1997). The
conversion of the carbon skeleton of glutamate to a-KG can
take place by two different enzymatic pathways, i.e. via the
GDH-catalysed oxidative deamination or by transamination
(Figure 3). The latter process may be catalysed by any
aminotransferase, but since AAT (aspartate aminotransferase)
is the member of this family of enzymes having by far the
highest activity in the brain (Erecinska and Silver, 1990), this
is the most likely enzyme to catalyse this reaction. It is
probable that oxidative deamination catalysed by GDH plays a
prominent role, since the aminotransferase inhibitor AOAA
(aminooxyacetic acid) in several studies has been shown to
inhibit oxidation of glutamate in the TCA cycle (e.g. Yu et al.,
1982; Westergaard et al., 1996). The conclusion from the
above-mentioned considerations is that a substantial fraction
of the glutamate taken up into astrocytes during glutama-
tergic activity is oxidatively metabolized in the TCA cycle (see
Westergaard et al., 1995) and hence, the glutamate–
glutamine cycle is not operating stoichiometrically
(McKenna et al., 2012). This imposes a need for de novo
synthesis of the glutamate carbon skeleton which is
dependent on the pyruvate carboxylase reaction that, like
GS, is confined to astrocytes (Yu et al., 1983). It should also be
pointed out that oxidation of the carbon skeleton of
glutamate, i.e. a-KG, requires pyruvate recycling (Figure 3),
a process that has been shown to occur in astrocytes
(Sonnewald et al., 1996; Waagepetersen et al., 2002). In this
pathway, malate originating from the TCA cycle is converted
to pyruvate by malic enzyme and subsequently decarboxy-
lated by pyruvate dehydrogenase and oxidized in the TCA
cycle (Bak et al., 2007; Obel et al., 2012).
The demonstration of a significant albeit low activity of
PAG in cultured astrocytes (Schousboe et al., 1979) is
compatible with the observation that glutamine can be
oxidatively metabolized in astrocytes after conversion to
first glutamate and then a-KG (Yu and Hertz., 1983; Hertz
et al., 1988). In line with this, the use of
13C-labelled
glutamine and MR spectroscopy has demonstrated sub-
stantial metabolism of glutamine in astrocytes, a process
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193coupled to pyruvate recycling (Sonnewald et al., 1996).
Metabolism of glutamine via PAG leads to production of
not only glutamate but also ammonia and in the case
of glutamate is oxidatively metabolized by GDH and an
additional molecule of ammonia is produced. This ammonia
must eventually be disposed of which likely occurs pre-
dominantly by conversion of glutamate to glutamine by GS.
The fact that the PAG- and GS-catalysed reactions are
intracellularly separated taking place in the mitochondrial
(PAG) and the cytoplasmic (GS) compartments respectively,
allows regulatory control. Nevertheless, exposure of astro-
cytes to elevated glutamine concentrations leads to adverse
effects on mitochondria caused by ammonia liberated in
the PAG reaction as demonstrated by Jayakumar et al.
(2004).
Astrocytic uptake and metabolism of GABA appears to be
of importance for the functional capacity of GABAergic
neurotransmission, since inhibitors of astrocytic GABA
transporters as well as GABA-T (GABA-aminotransferase)
act as anticonvulsants (Sarup et al., 2003; Schousboe et al.
2010). GABA will be metabolized into succinic semi-aldehyde
in the astrocytic mitochondria that contain appreciable
activity of GABA-T (Waagepetersen et al., 2009). Succinic
semi-aldehyde dehydrogenase catalyses the subsequent
oxidation of succinic semi-aldehyde to succinate which may
be used for glutamate and glutamine synthesis via conversion
to a-KG using acetyl-CoA from glucose metabolism
(Waagepetersen and Schousboe, 2007) or oxidized to CO2
via pyruvate recycling.
METABOLIC COMPARTMENTATION OF
ENERGY METABOLISM
Metabolic compartmentation at the level of the single cell is
defined as the presence of multiple, distinct intracellular
pools of identical metabolites that are not in equilibrium.
The energy metabolism of astrocytes in culture has been
shown numerous times to be compartmentalized (Schousboe
et al., 1993; Sonnewald et al., 1993; Bouzier et al., 1998;
Qu et al., 1999; Cruz et al., 2001; Waagepetersen et al., 2001,
2006; Zwingmann et al., 2001). As mentioned above, the
pyruvate pool seems to be highly compartmentalized
(Figure 4) since lactate released from cultured astrocytes is
derived from the metabolism of extracellular glucose but not
breakdown of glycogen (Sickmann et al., 2005). This may be
difficult to understand since metabolites are seemingly
diffusing freely inside the aqueous environment of the cell.
There are several possible answers to this; importantly, the
intracellular compartment of an astrocyte, or indeed any
cell, cannot be regarded as being analogous to a glass of
water with all metabolites existing in a thermodynamically
Figure 4 Schematic presentation of multiple compartments in astrocytes
Synthesis of a large amount of releasable citrate via pyruvate carboxylase occurs in compartment A, a compartment for preferential
glucose metabolism. Releasable glutamine is synthesized from glutamate originating from compartments B and C. Glucose is the main
oxidative substrate for compartment B, whereas lactate and glucose are metabolized to the same extent in compartments C and D.
The main intracellular pool of glutamine is synthesized from glutamate originating from compartment D. The size of the arrows
provide an estimate of the relative magnitudes of the respective fluxes. GLN, glutamine; GLU, glutamate; CIT, citrate; OAA,
oxaloacetate; ASP, aspartate; FUM, fumarate.
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environment containing highc o n c e n t r a t i o n so fs m a l l
metabolites, macromolecules, ions and multiple membrane-
bound boundaries between organelles. These aspects are
discussed in an almost 30-year-old review by Clegg (1984).
Interestingly, recent mathematical modelling of the dif-
fusion of metabolites inside cells shows that cytosolic
compartmentation of high-concentration metabolites (e.g.
glucose, lactate, pyruvate and ATP) due to molecular sinks
such as enzymes and transporters should not be possible and
that such compartmentation is restricted to signalling
molecules such as cytosolic Ca
2+ (Martinez et al., 2010;
Barros and Martinez, 2007). Thus, metabolic compartmenta-
tion may not arise due to localized consumption of e.g. ATP
or glucose. However, a number of issues complicate matters
somewhat. First, the astrocyte (as well as the neuron) has a
complex morphology and may be divided into functional
domains (Kimelberg and Nedergaard, 2010). Secondly, as
implied above, the astrocyte may be regarded as a crowded
place; metabolites and organelles are moving around in a
morphologically and functionally complex manner and
diverse cell in a semi-aqueous cytosolic environment with
internal physical barriers (i.e. organellar membranes) to
isotropic diffusion. Previous work in cardiomyocytes has
shown that diffusion of ATP is anisotropic and 2–3 times
slower than in dilute solution (Vendelin and Birkedal, 2008);
these authors suggested that the anisotropy was caused by
intracellular membranes hindering diffusion. Whether a 2–3
times slower rate of diffusion is sufficient to contribute to
intracellular compartmentation of metabolism remains to be
established. Thirdly, the existence of functionally and
metabolically heterogeneous pools of mitochondria has
been suggested and indeed mitochondria are very dynamic
and heterogeneous organelles (Hollenbeck and Saxton, 2005;
Waagepetersen et al., 2001). Lastly, some (astrocytic)
biochemical processes, such as ATP-consuming membrane
pumps, depend on ATP produced by substrate-level phos-
phorylation in the glycolytic pathway rather than the bulk
pool of ATP; this might be explained by the formation of
supramolecular complexes of enzymes and transporters such
that at least some glycolytic ATP never enters the bulk
cytosol (Schousboe et al., 2011). Solid evidence at the
molecular level that mitochondria are indeed metabolically
heterogeneous came from an immunogold-labelling experi-
ment in cultured astrocytes conducted by Waagepetersen
et al. (2006). Electron microscopic investigation of immuno-
gold-labelled a-KG dehydrogenase, a key TCA cycle enzyme,
showed heterogeneous distribution among mitochondria
within the same cell, indicating differential capacity for
mitochondria to perform oxidative metabolism. This implies
thatsomemitochondria may betuned toproduceenergyinthe
form of ATP, whereas others may be tuned to perform a different
task, e.g. anaplerotic reactions for synthesis of glutamine for
export to neurons as a precursor for neurotransmitter glutamate
and GABA synthesis (Figure 4 and Waagepetersen et al., 2001).
Indeed, metabolic compartmentation of astrocytic (energy)
metabolism is complex and much is still left to be learned about
this subject.
CONCLUDING REMARKS
Brown and Prior (2006) noted that over the last few decades
the methods to study brain-energy metabolism have evolved
from inflating a pneumatic cuff in order to occlude the
carotid arteries in ‘volunteer’ prisoners, to MRI (magnetic
resonance imaging). They also note that there is a ‘‘desire to
measure energy metabolism in a single cell (or even different
regions of a single cell) in the brain in real-time’’ (Brown and
Prior, 2006). However, some years ago this was not possible
d u et oal i m i t e ds p a t i a la n d temporal resolution of
monitoring techniques. New implications of FRET-based
nanosensors may exemplify such a high spatial and high
temporal resolution technique to address brain energy
metabolism at the subcellular level.
Pertinent research questions to be asked are many when it
comes to subcellular compartmentation of (energy) meta-
bolism, such as why are seemingly identical metabolic
pathways such as glycolysis starting from extracellular
glucose segregated from glycolysis starting from glucose-6-
phosphate derived from breakdown of glycogen? And, are
metabolically heterogeneous mitochondria localized to dif-
ferent cellular compartments? Heterogeneous populations of
mitochondria between organs have been shown and might be
therapeutically targeted (Jayakumar et al., 2007); in the same
way, it might in the future be both desirable and possible to
target specific cellular populations of mitochondria, the latter
e.g. based on differences in their membrane potential.
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